PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Luigi Fattore, Elisa Melucci, Fabio Pelle, Claudio Botti et al.
Citations
1 citations
Journal
Journal of Experimental & Clinical Cancer Research
Topics
Protein Degradation and Inhibitors
Field-Weighted Citation Impact (FWCI)
22.24
article
PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Luigi Fattore, Elisa Melucci, Fabio Pelle, Claudio Botti, Rita Mancini, Marta Di Martile, Marica Di Caprio, Elisabetta Valentini, Simona D’Aguanno, Donatella Del Bufalo, Matteo Brignone, Arianna Ortolano, Dante Rotili, Adriana Maria Di Stefano, Giulia Gentile, Gennaro Ciliberto
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Experimental & Clinical Cancer ResearchVol. 45(1)
Institutions
University of Siena (IT), Roma Tre University (IT), Azienda Ospedaliera Sant'Andrea (IT), Unitelma Sapienza University (IT), National Cancer Institute (MY), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Link Campus University (IT), Sapienza University of Rome (IT)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models — Luigi Fattore, Elisa Melucci, et al. · Journal of Experimental & Clinical Cancer Research (2026) | TGRS Research Map | TGRS